Bill > H4205

This bill mandates that various health insurance providers in the Commonwealth must cover treatments for mitochondrial disease, a group of genetic disorders that affect the energy-producing part of cells, known as mitochondria. Specifically, it requires coverage for treatments that include vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine. This coverage applies to state employees' health plans, the state's medical assistance program (often referred to as MassHealth), accident and sickness insurance policies, hospital and medical service plans, and health maintenance organizations (HMOs), ensuring that individuals with mitochondrial disease have access to these specific therapeutic options.